Ayre J, Bonner C, Muscat DM, Dunn AG, Harrison E, Dalmazzo J, et al. Multiple Automated Health Literacy Assessments of Written Health Information: Development of the SHeLL (Sydney Health Literacy Lab) Health Literacy Editor v1. JMIR Form Res 2023;7:e40645. https://www.ncbi.nlm.nih.gov/pubmed/36787164
Bowen AC, Tong SY, Andrews RM, O'Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet 2014;384(9960):2132-40. http://www.ncbi.nlm.nih.gov/pubmed/25172376
Katzenellenbogen JM, Bond-Smith D, Seth RJ, Dempsey K, Cannon J, Stacey I, et al. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change. J Am Heart Assoc 2020;9(19):e016851. https://www.ncbi.nlm.nih.gov/pubmed/32924748
Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev 2012;1(1):CD003261. https://www.ncbi.nlm.nih.gov/pubmed/22258953
May PJ, Tong SYC, Steer AC, Currie BJ, Andrews RM, Carapetis JR, et al. Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review. Trop Med Int Health 2019;24(3):280-93. https://www.ncbi.nlm.nih.gov/pubmed/30582783
RHDAustralia (ARF/RHD writing group). The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition). Darwin, NT: RHD Australia; 2020. https://www.rhdaustralia.org.au/arf-rhd-guideline